𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model

✍ Scribed by Franck Le Guerhier; Alexandre Thermet; Sylvianne Guerret; Michèle Chevallier; Catherine Jamard; Craig S. Gibbs; Christian Trépo; Lucyna Cova; Fabien Zoulim

Book ID
118564891
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
254 KB
Volume
38
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiviral strategies in chronic hepatiti
Antiviral strategies in chronic hepatitis B virus infection: I. Establishment of an in vitro system using the duck hepatitis B virus model
✍ Naomi Bishop; Gilda Civitico; Yanyan Wang; Kejian Guo; Chris Birch; Ian Gust; Dr 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 947 KB

## Abstract Primary duck hepatocyte (PDH) cultures were established from ducklings congenitally infected with the duck hepatitis B virus (DHBV), plated onto feeder cell layers of irradiated human embryonic lung fibroblasts, and observed for 2 to 3 weeks. This system permitted the survival of the PD

Antiviral strategies in chronic hepatiti
Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B Virus in vitro using conventional antiviral agents and supercoiled-DNA active compounds
✍ Gilda Civitico; Yanyan Wang; Carolyn Luscombe; Naomi Bishop; Gilda Tachedjian; I 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 880 KB

## Abstract Primary duck hepatocyte (PDH) cultures, congenitally infected with the duck hepatitis B virus (DHBV), were grown on feeder cell layers of irradiated human embryonic lung fibroblasts and then exposed to a number of compounds with recognized or potential antiviral activity. These compound

Efficacy of hepatitis B vaccine against
Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model
✍ Saleem Kamili; Vitini Sozzi; Geoff Thompson; Katie Campbell; Christopher M. Walk 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

Hepatitis B virus (HBV) mutants resistant to treatment with nucleoside or nucleotide analogs and those with the ability to escape from HBV-neutralizing antibody have the potential to infect HBV-vaccinated individuals. To address this potential serious public health challenge, we tested the efficacy